DULERA My 6-Month Asthma Story
My 6-Month Asthma Story is designed to help patients work with their HCPs to make a better plan for long-term asthma care.
One of the active ingredients in DULERA increases the risk of asthma-related death. Therefore, DULERA should only be taken by patients not adequately controlled on a long-term asthma control medication. Once asthma control is achieved and maintained on DULERA, therapy needs to be stepped down and patients need to be assessed at regular intervals. Eventually DULERA should be discontinued without loss of asthma control and patients should be switched to a long-term asthma control medication, such as an inhaled corticosteroid.
Because DULERA is not a rescue therapy for acute episodes of bronchospasm, HCPs must also provide patients with an inhaled, short-acting treatment of acute symptoms, despite regular twice-daily (morning and evening) use of DULERA.